Evidence map›Paper›PMID 41212330›Full record

ArticleEuropean journal of pediatrics2025

Transient pseudohypoaldosteronism type I in infants with urinary tract infections and/or uropathy: insights from a French multicenter cohort.

Inès Bernhard, Claire Dossier, Laura Bianchi, Cyrielle Parmentier, Tim Ulinski, Laurence Heidet, Isabelle Talon, Élise Petit, Massimiliano Bertacchi, Justine Perrin and 6 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Inès BernhardService de Pédiatrie 1, CHU Hautepierre, Strasbourg, France. ines.bernhard@chru-strasbourg.fr.
Claire DossierService de Néphrologie Pédiatrique, CHU Robert Debré, APHP, Paris, France.
Laura BianchiDepartement of Pediatrics, Parma Children's Hospital, Parma, Italy.
Cyrielle ParmentierService de Néphrologie Pédiatrique, CHU Trousseau, Paris, France.
Tim UlinskiService de Néphrologie Pédiatrique, CHU Trousseau, Paris, France.
Laurence HeidetService de Néphrologie PédiatriqueLaboratoire Des Maladies Rénales Héréditaires InsermUMR U1163, Centre de Référence MARHEA, Hôpital Universitaire Necker Enfants Malades AP-HP, Université Paris Cité Institut Imagine, Paris, France.
Isabelle TalonService de Chirurgie Pédiatrique, CHU Hautepierre, Strasbourg, France.
Élise PetitService de Pédiatrie, CH du Havre, Le Havre, France.
Massimiliano BertacchiPediatric Nephrology Unit, Geneva University Hospitals, Geneva, Switzerland.
Justine PerrinService de Pédiatrie, Toulon, France.
Ania BenniourService de Néphrologie Pédiatrique, CHU Lille, Lille, France.
Elise PaugamService de Néphrologie Pédiatrique, CHU Lille, Lille, France.
Sylvie CloarecService de Pédiatrie, Tours, France.
Violaine LefrancService de Pédiatrie, Tours, France.
Sylvie RossignolService de Pédiatrie 1, CHU Hautepierre, Strasbourg, France.
Ariane ZaloszycService de Pédiatrie 1, CHU Hautepierre, Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the first year of life, and especially in the first 6 months, urinary tract infections, congenital anomalies of the kidney and urinary tract (CAKUT)-particularly obstructive types-and the coexistence of both factors may lead to transient resistance to aldosterone. This condition is characterized by fluid and salt loss despite significant activation of the renin-angiotensin-aldosterone system, and by electrolyte disturbance featuring hyponatremia, hyperkalemia, and metabolic acidosis with a normal anion gap. Transient resistance to aldosterone is not widely recognized by clinicians. Our objective was to describe the clinical presentations and management strategies in order to propose a comprehensive diagnostic approach.

methodsWe conducted a 13-year retrospective study involving 35 children from eight centers across France, as well as one child from Switzerland.

resultsMost of the children in our cohort were under 6 months of age (68.6% male). The clinical presentation of pseudohypoaldosteronism was variable and often similar to that of adrenal insufficiency. The pyelonephritis diagnosis was retained in 94.3% of the cases and uropathy was present in 85.7% of the children. Treatment was primarily symptomatic, and included intravenous hydration, salt supplementation, correction of potassium levels, and antibiotic therapy when pyelonephritis was diagnosed.

conclusionTransient type I pseudohypoaldosteronism should be promptly considered in any infant presenting with a deteriorating general condition and fluid and electrolyte imbalances, particularly hyponatremia and hyperkalemia, in the context of acute pyelonephritis and/or uropathy. WHAT IS KNOWN: • Transient type I pseudohypoaldosteronism affects infants under 1 year of age with congenital anomalies of the kidney and urinary tract during acute pyelonephritis. • Treatment mostly consists of antibiotics and parenteral fluids. WHAT IS NEW: • This is the first article to report on 34 cases from a single country. • The importance of renal ultrasound in the context of urinary tract infection with salt wasting symptoms in infants without known congenital anomalies the kidney and urinary tract. • The importance of assessing hydro-electrolytic status in cases of urinary tract infection in infants under 6 months with or without known congenital anomalies of the kidney and urinary tract. • A decision tree for the diagnostic approach of transient type I pseudohypoaldosteronism.

Indexed as

PseudohypoaldosteronismUrinary Tract InfectionsFemaleFranceHumansInfantInfant, NewbornMalePyelonephritisRetrospective StudiesSwitzerlandCongenital anomaliesHyperkalemiaPseudohypoaldosteronismPyelonephritis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.